Foxx Blog
Foxx In News 2025VersaCap® Technology Aids Critical Vaccine Trial, NBC Nightly News
Moderna continues to run the COVID-19 vaccine trials. They aim to enroll 30,000 adults in the clinical trial, which is designed to test whether the vaccine works to prevent COVID-19. The trial will also look at the vaccine's safety. Participants will either receive the vaccine or a placebo. They will be tracked for two years to see whether they get COVID-19 or have any adverse reactions to the vaccine. In an editorial published alongside the study, Dr. Penny Heaton, the chief executive officer of the Bill and Melinda Gates Research Institute in Cambridge, Massachusetts, wrote that the data are "promising." (Footage...